Correlation Between Merck KGaA and Cannabis Suisse

Can any of the company-specific risk be diversified away by investing in both Merck KGaA and Cannabis Suisse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck KGaA and Cannabis Suisse into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck KGaA ADR and Cannabis Suisse Corp, you can compare the effects of market volatilities on Merck KGaA and Cannabis Suisse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck KGaA with a short position of Cannabis Suisse. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck KGaA and Cannabis Suisse.

Diversification Opportunities for Merck KGaA and Cannabis Suisse

0.15

Correlation Coefficient

Merck KGaA  Cannabis Suisse

Average diversification

The 3 months correlation between Merck and Cannabis is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Merck KGaA ADR and Cannabis Suisse Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Suisse Corp and Merck KGaA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck KGaA ADR are associated (or correlated) with Cannabis Suisse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Suisse Corp has no effect on the direction of Merck KGaA i.e., Merck KGaA and Cannabis Suisse go up and down completely randomly.

Pair Corralation between Merck KGaA and Cannabis Suisse

Assuming the 90 days horizon Merck KGaA ADR is expected to under-perform the Cannabis Suisse. But the pink sheet apears to be less risky and, when comparing its historical volatility, Merck KGaA ADR is 27.35 times less risky than Cannabis Suisse. The pink sheet trades about -0.05 of its potential returns per unit of risk. The Cannabis Suisse Corp is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  1.90  in Cannabis Suisse Corp on December 2, 2024 and sell it today you would lose (0.20) from holding Cannabis Suisse Corp or give up 10.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.31%
Values	Daily Returns

Merck KGaA ADR  vs.  Cannabis Suisse Corp

Merck KGaA ADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days Merck KGaA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Merck KGaA is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cannabis Suisse Corp

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Suisse Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Cannabis Suisse demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Merck KGaA and Cannabis Suisse

The main advantage of trading using opposite Merck KGaA and Cannabis Suisse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck KGaA position performs unexpectedly, Cannabis Suisse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Suisse will offset losses from the drop in Cannabis Suisse's long position.

The idea behind Merck KGaA ADR and Cannabis Suisse Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.